Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036. Case and Commentary Apr 2016 Is Proxy Consent for an Invasive Procedure on a Patient with Intellectual Disabilities Ethically Sufficient? Commentary 2 Sonya Charles, PhD Women with intellectual disabilities should not be sedated for a pap smear without their assent, and the test’s risks and benefits should be weighed. AMA J Ethics. 2016;18(4):379-383. doi: 10.1001/journalofethics.2016.18.4.ecas3-1604. Case and Commentary Jul 2019 How Should Clinicians Navigate Decision Making for Unrepresented Patients? Timothy M. Dempsey, MD, MPH and Erin Sullivan DeMartino, MD A deliberative approach to responding to needs and vulnerabilities of unrepresented patients can help make the most of having too little information. AMA J Ethics. 2019;21(7):E559-565. doi: 10.1001/amajethics.2019.559. Case and Commentary Apr 2016 Considering Decision Making and Sexuality in Menstrual Suppression of Teens and Young Adults with Intellectual Disabilities Kruti Acharya, MD and John D. Lantos, MD A guardian’s request to sterilize a woman with intellectual disabilities is not ethically justifiable unless the woman assents and it is to her benefit. AMA J Ethics. 2016;18(4):365-372. doi: 10.1001/journalofethics.2016.18.4.ecas2-1604. Case and Commentary May 2020 How Should Adolescent Health Decision-Making Authority Be Shared? Kimberly Sawyer, MD and Abby R. Rosenberg, MD, MS, MA Shared decision making is complex with patients who are adolescents, whose relational autonomy is still emerging. AMA J Ethics. 2020;22(5):E372-379. doi: 10.1001/amajethics.2020.372. Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345. Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353. Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361. Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368. Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036.
Case and Commentary Apr 2016 Is Proxy Consent for an Invasive Procedure on a Patient with Intellectual Disabilities Ethically Sufficient? Commentary 2 Sonya Charles, PhD Women with intellectual disabilities should not be sedated for a pap smear without their assent, and the test’s risks and benefits should be weighed. AMA J Ethics. 2016;18(4):379-383. doi: 10.1001/journalofethics.2016.18.4.ecas3-1604.
Case and Commentary Jul 2019 How Should Clinicians Navigate Decision Making for Unrepresented Patients? Timothy M. Dempsey, MD, MPH and Erin Sullivan DeMartino, MD A deliberative approach to responding to needs and vulnerabilities of unrepresented patients can help make the most of having too little information. AMA J Ethics. 2019;21(7):E559-565. doi: 10.1001/amajethics.2019.559.
Case and Commentary Apr 2016 Considering Decision Making and Sexuality in Menstrual Suppression of Teens and Young Adults with Intellectual Disabilities Kruti Acharya, MD and John D. Lantos, MD A guardian’s request to sterilize a woman with intellectual disabilities is not ethically justifiable unless the woman assents and it is to her benefit. AMA J Ethics. 2016;18(4):365-372. doi: 10.1001/journalofethics.2016.18.4.ecas2-1604.
Case and Commentary May 2020 How Should Adolescent Health Decision-Making Authority Be Shared? Kimberly Sawyer, MD and Abby R. Rosenberg, MD, MS, MA Shared decision making is complex with patients who are adolescents, whose relational autonomy is still emerging. AMA J Ethics. 2020;22(5):E372-379. doi: 10.1001/amajethics.2020.372.
Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345.
Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353.
Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361.
Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368.
Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376.